BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25304795)

  • 1. 20-year experience with intraoperative high-dose-rate brachytherapy for pediatric sarcoma: outcomes, toxicity, and practice recommendations.
    Folkert MR; Tong WY; LaQuaglia MP; Wexler LH; Chou AJ; Magnan H; Zelefsky MJ; Wolden SL
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):362-8. PubMed ID: 25304795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of intraoperative radiotherapy for upper-extremity soft-tissue sarcomas: analysis of disease outcomes and toxicity.
    Call JA; Stafford SL; Petersen IA; Haddock MG
    Am J Clin Oncol; 2014 Feb; 37(1):81-5. PubMed ID: 23111357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative high-dose-rate brachytherapy using dose painting technique: evaluation of safety and preliminary clinical outcomes.
    Morikawa LK; Zelefsky MJ; Cohen GN; Zaider M; Chiu J; Mathur N; Worman MF; Goodman KA
    Brachytherapy; 2013; 12(1):1-7. PubMed ID: 23167979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative high-dose-rate brachytherapy for pediatric solid tumors: a 10-year experience.
    Goodman KA; Wolden SL; LaQuaglia MP; Alektiar K; D'Souza D; Zelefsky MJ
    Brachytherapy; 2003; 2(3):139-46. PubMed ID: 15062136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative radiotherapy of soft tissue sarcoma of the extremity.
    Kretzler A; Molls M; Gradinger R; Lukas P; Steinau HU; Würschmidt F
    Strahlenther Onkol; 2004 Jun; 180(6):365-70. PubMed ID: 15175871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative radiation therapy for locally advanced and recurrent soft-tissue sarcomas in adults.
    Tran PT; Hara W; Su Z; Lin HJ; Bendapudi PK; Norton J; Teng N; King CR; Kapp DS
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1146-53. PubMed ID: 18394818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative hyperfractionated high-dose rate brachytherapy for the treatment of soft tissue sarcomas: multicentric experience.
    Petera J; Soumarová R; Růzicková J; Neumanová R; Dusek L; Sirák I; Macingová Z; Paluska P; Kasaová L; Hodek M; Vosmik M
    Ann Surg Oncol; 2010 Jan; 17(1):206-10. PubMed ID: 19711130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brachytherapy in the combined modality treatment of pediatric malignancies. Principles and preliminary experience with treatment of soft tissue sarcoma (recurrence) and Ewing's sarcoma.
    Pötter R; Knocke TH; Kovacs G; Schmilowski GM; Haverkamp U; Hawliczek R; Seitz W; Rübe C; Wuisman P; Maragakis G
    Klin Padiatr; 1995; 207(4):164-73. PubMed ID: 7564147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer.
    Perry DJ; Chan K; Wolden S; Zelefsky MJ; Chiu J; Cohen G; Zaider M; Kraus D; Shah J; Lee N
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1140-6. PubMed ID: 19560882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience.
    Hyngstrom JR; Tzeng CW; Beddar S; Das P; Krishnan S; Delclos ME; Crane CH; Chang GJ; You YN; Feig BW; Skibber JM; Rodriguez-Bigas MA
    J Surg Oncol; 2014 Jun; 109(7):652-8. PubMed ID: 24510523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative radiation therapy for pediatric sarcomas and other solid tumors.
    Conte B; Casey DL; Tringale KR; LaQuaglia MP; Gerstle JT; Wexler L; Ortiz MV; Wolden SL
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30949. PubMed ID: 38520048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant high-dose-rate and low-dose-rate brachytherapy with external beam radiation in soft tissue sarcoma: a comparison of outcomes.
    Pohar S; Haq R; Liu L; Koniarczyk M; Hahn S; Damron T; Aronowitz JN
    Brachytherapy; 2007; 6(1):53-7. PubMed ID: 17284387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes with intraoperative radiotherapy as a component of treatment for locally advanced or recurrent uterine sarcoma.
    Barney BM; Petersen IA; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):191-7. PubMed ID: 21985942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas.
    Alektiar KM; Hu K; Anderson L; Brennan MF; Harrison LB
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):157-63. PubMed ID: 10758318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve tolerance to high-dose-rate brachytherapy in patients with soft tissue sarcoma: a retrospective study.
    Kubo T; Sugita T; Shimose S; Matsuo T; Hirao K; Kimura H; Kenjo M; Ochi M
    BMC Cancer; 2005 Jul; 5():79. PubMed ID: 16026629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer.
    Teckie S; Scala LM; Ho F; Wolden S; Chiu J; Cohen GN; Wong R; Ganly I; Zelefsky MJ; Lee NY
    Brachytherapy; 2013; 12(3):228-34. PubMed ID: 23466361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.